Allergic conjuntivitis

Most frequently reported  ocular adverse reactions occuring in approximately  1% to 10% of patients were -  burning sensation in the eye, folliculitis,hyperermia  and pruritus

Most frequently reported non- ocular adverse reactions were-
infection ( cold symptoms and upper respiratory infection ) seen in approx 8% and
headache, rhinitis, sinusitis, increased cough,  and pharynginitis in approx 2% of cases

Hypersensitivity to epinastine or any other components

Special Precautions/ Warning-

Administration- Epinastine Hydrochoride is for topical ophthalmic use only and not for
injection or oral use.

Contact lenses- advice patients not to wear a contact lenses if their eyes are red.
Do not use epinastine to treat contact lenses related irritation

Contact lenses should be removed prior to instillation and may be reinserted  after
 10 minutes  following its administration.

Administration- instruct patients to avoid the tip  of the dispensing container to contact the eye, surrounding strictures , fingers or any other surface to prevent contamination of the solution by common bacteria to cause ocular infections

Serious damage to the eye and subsequent loss of vision may result from using contaminated  solutions

Pregnancy - epinastine ophthalmic solution should be used during pregnancy only if the
potential justifies the potential risk to the fetus.

Lactation- caution should be excercised when epinastine ophthalmic solution is administered to a nursing woman

Children- safety and effectiveness in pediatric younger than the age of 3 years have not been established

Elderly - No overall differences in safety or effectiveness have been observed between elderly and younger patients 

Indication-

Allergic conjuntivitis

Dosage-

Recommended dose is 1 drop in each eye twice a day

Store - at 15 to 25C  ( 59 to 77F ). Keep out of reach of children

1.  Epinastine Hydrochoride is for topical ophthalmic use only and not for
   injection or oral use.

2. Advice patients not to wear a contact lenses if their eyes are red.
    Do not use epinastine to treat contact lenses related irritation

3. Contact  lenses should be removed prior to instillation and may be reinserted  after
   10 minutes  following its administration.

4. Instruct patients to avoid the tip  of the dispensing container to contact the eye,
surrounding strictures , fingers or any other surface to prevent contamination of the solution by common bacteria to cause ocular infections

5. Serious damage to the eye and suscequent loss of vision may result from using contaminated  solutions

6. Keep bottle tightly closed when not in use.

Pregnancy -
Epinastine ophthalmic solution should be used during pregnancy only if the
potential justifies the potential risk to the fetus.

Lactation-
Caution should be excercised when epinastine ophthalmic solution is administered
to a nursing woman

Children-
Safety and effectiveness in pediatric patients younger than the age of 3 years have not been
established

Elderly -
 No overall differences in safety or effectiveness have been observed between elderly
and younger patients